We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · January 25, 2022

Methylation Markers for Early Detection of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis

Hepatology (Baltimore, Md.)


Additional Info

Disclosure statements are available on the authors' profiles:

Hepatology (Baltimore, Md.)
Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile
Hepatology 2022 Jan 01;75(1)59-73, HM Vedeld, MM Grimsrud, K Andresen, HD Pharo, E von Seth, TH Karlsen, H Honne, V Paulsen, MA Färkkilä, A Bergquist, M Jeanmougin, L Aabakken, KM Boberg, T Folseraas, GE Lind

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading